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Objectives The objective of this study is to evaluate the predictive value of the index of microcirculatory resistance (IMR) in
patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial in-
farction (STEMI).
Background Despite adequate epicardial artery reperfusion, a number of patients with STEMI have a poor prognosis because
of microvascular damage. Assessing the status of the microvasculature in this setting remains challenging.
Methods In 29 patients after primary PCI for STEMI, IMR was measured with a pressure sensor/thermistor-tipped guide-
wire. The Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grade, TIMI frame count, coronary
flow reserve, and ST-segment resolution were also recorded.
Results The IMR correlated significantly with the peak creatinine kinase (CK) (R  0.61, p  0.0005) while the other mea-
sures of microvascular dysfunction did not. In patients with an IMR greater than the median value of 32 U, the peak
CK was significantly higher compared with those having values 32 U (3,128  1,634 ng/ml vs. 1,201  911 ng/
ml, p  0.002). The IMR correlated significantly with 3-month echocardiographic wall motion score (WMS) (R  0.59,
p  0.002) while the other measures of microvascular function did not. The WMS at 3-month follow-up was signifi-
cantly worse in the group with an IMR 32 U compared with 32 U (28  7 vs. 20  4, p  0.001). On multivariate
analysis, IMR was the strongest predictor of peak CK and 3-month WMS. The IMR was the only significant predictor of
recovery of left ventricular function on the basis of the percent change in WMS (R  0.50, p  0.01).
Conclusions Compared to standard measures, IMR appears to be a better predictor of microvascular damage after STEMI,
both acutely and in short term follow-up. (J Am Coll Cardiol 2008;51:560–5) © 2008 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.062m
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wespite achieving normal epicardial coronary artery flow
fter primary percutaneous coronary intervention (PCI) for
T-segment elevation myocardial infarction (STEMI), a
ignificant proportion of patients have a poor outcome
ecause of microvascular coronary damage (1,2). However, a
See page 566
elatively simple quantitative method for evaluating the
tatus of the microcirculation in individual patients with
TEMI at the time of cardiac catheterization is lacking.
rom the Division of Cardiovascular Medicine, Stanford University Medical Center,
tanford, California. This work was supported in part by grant 1 K23 HL072808-
1A1 (to Dr. Fearon) from the National Institutes of Health, Heart, Lung, and Blood
nstitute, Bethesda, Maryland.t
Manuscript received June 12, 2007; revised manuscript received August 7, 2007,
ccepted August 27, 2007.The index of microcirculatory resistance (IMR) is a new
easure of microvasculature function using a pressure
ensor/thermistor-tipped guidewire. The IMR has been
alidated in an animal model and tested in stable patients
3–7). The potential advantages of IMR over current
ethods for evaluating the microcirculation are its relative
ase of performance and interpretation, its quantitative
ature, its independence of the epicardial vessel, and its
eproducibility. The goal of this study is to evaluate the
bility of IMR measured after primary PCI for STEMI for
redicting myocardial damage compared to other traditional
ethods for assessing the microvasculature.
ethods
emodynamically stable patients presenting with STEMI
ithin 12 h of onset of symptoms or after failed fibrinolytic
herapy who had persistent ST-segment elevation 1 mm
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February 5, 2008:560–5 IMR in STEMIn contiguous leads on the electrocardiogram and who
rovided informed written consent were enrolled in this
tudy. The study was approved by Stanford’s Administrative
anel on Human Subjects in Medical Research.
hysiologic measurements. Primary PCI was performed in
he standard fashion. Timing of and use of adjunctive
harmacology such as platelet glycoprotein IIb/IIIa receptor
nhibitors was left to the discretion of the primary operator.
fter successful stenting of the culprit lesion, a coronary
ressure wire (Radi Medical Systems, Uppsala, Sweden) was
alibrated outside the body, equalized to the pressure
eading from the guide catheter with the pressure sensor
ositioned at the ostium of the guide catheter, and then
dvanced to the distal two-thirds of the culprit vessel, which
n the vast majority was beyond the stented region.
The IMR and thermodilution-derived coronary flow
eserve (CFR) were calculated as previously described (3,8–
0). In brief, 3 ml of room-temperature saline were injected
own the culprit vessel 3 times at rest, and the resting transit
imes, which are inversely proportional to flow, were re-
orded and averaged. Maximal hyperemia was then induced
sing either a single bolus of 10 to 15 g of intracoronary
apaverine or 140 g/kg/min of intravenous adenosine via a
entral venous catheter. Three milliliters of room-
emperature saline were again injected down the culprit
essel, and the hyperemic transit times were recorded and
veraged. The mean aortic and distal coronary pressures
ere recorded during peak hyperemia.
The IMR was defined as distal coronary pressure divided
y flow during peak hyperemia and calculated by dividing
he mean distal coronary pressure by the inverse of the
yperemic transit time, or, more simply, multiplying the
ean distal coronary pressure by the hyperemic transit time
mm Hg  s, or U). Coronary flow reserve was defined as
he mean resting transit time divided by the mean hyper-
mic transit time. Fractional flow reserve (FFR) was calcu-
ated by dividing the mean distal coronary pressure by the
ean aortic pressure during maximal hyperemia.
After the procedure, the distance from the ostium of the
essel to the position of the pressure sensor was measured
nd recorded by fastening the torque device to the wire at
he hub of the Y-connector with the wire still down the
essel and then measuring the amount of wire pulled out of
he catheter to position the pressure sensor at the ostium of
he vessel. Knowing the distance may be important, given
hat the mean transit time is affected by large differences in
ensor distance.
ther measures of microvascular function. The Throm-
olysis In Myocardial Infarction (TIMI) myocardial perfu-
ion grade (TMPG) was assessed from the final recorded
ine images after completion of the procedure as previously
escribed (2). If necessary, the view was adjusted so that the
ulprit vessel territory was not superimposed on nonin-
arcted regions. The duration of cine filming was prolonged
t least 3 cardiac cycles to make sure that the entire washout
hase was included. The TMPG was assessed during the tame phase of the cardiac cycle.
he images were analyzed offline
ndependently by 2 interven-
ional cardiologists blinded to
he IMR result. Any discrepan-
ies were resolved by consensus.
he corrected Thrombolysis In
yocardial Infarction frame
ount (cTFC) was defined as the
umber of frames necessary for
he dye to reach standardized
istal landmarks, as previously
escribed (11). The left anterior
escending coronary artery frame
ounts were corrected by divid-
ng by 1.7.
An electrocardiogram was ob-
ained immediately before the
rocedure and within 1 h after
ompletion of the procedure.
he ST-segment elevation was
ummed from all of the infarct-
elated leads on the baseline elec-
rocardiogram and from the same
eads on the after-procedure electrocardiogram. The reso-
ution of the sum of ST-segment elevation (ST-segment
esolution) was expressed as a percentage from baseline, as
reviously described (12).
Total creatine kinase (CK) was measured every 8 h after
resentation until the total CK began to decline. Peak CK
as defined as the highest CK measured.
chocardiographic analysis. A transthoracic echocardio-
ram was obtained within 24 h of presentation. Follow-up
chocardiography was performed approximately 3 months
fter the acute event. A wall motion score (WMS) was
etermined by an experienced echocardiographer blinded to
he IMR results using a 16-segment model as previously
escribed (13). Each segment was visually analyzed and
cored from 1 to 5 (1  normal, 2  hypokinetic, 3 
kinetic, 4  dyskinetic, and 5  aneurysm). The final
MS was arrived at by adding the points for each segment. A
ower score implies better left ventricular function. The percent
hange in WMS was calculated by subtracting the follow-up
MS from the baseline WMS, dividing by the baseline
MS, and multiplying by 100%.
tatistics. Data are presented as mean  SD. The Wil-
oxon signed-rank test and the Mann-Whitney test were
sed for paired and unpaired comparisons, respectively.
easures of microvascular function and other clinical fea-
ures listed in Table 1 were compared to peak CK, 3-month
MS, and the percent change in WMS using linear
egression analysis. The three strongest univariate predictors
ere entered into a multivariate model to determine inde-
endent predictors. A p value 0.05 was considered statis-
Abbreviations
and Acronyms
CFR  coronary flow
reserve
CK  creatine kinase
cTFC  corrected
Thrombolysis In Myocardial
Infarction frame count
FFR  fractional flow
reserve
IMR  index of
microcirculatory resistance
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial Infarction
TMPG  Thrombolysis In
Myocardial Infarction
myocardial perfusion grade
WMS  wall motion scoreically significant.
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IMR in STEMI February 5, 2008:560–5esults
wenty-nine patients were enrolled in the study. In 1
atient, accurate thermodilution mean transit time measure-
ents could not be obtained. One patient died before
ollow-up echocardiographic data could be obtained, and 1
atient was lost to follow-up. The clinical features and
easures of microvascular function of the 28 included
atients are outlined in Table 1. The culprit vessel was the
eft anterior descending in 12 cases, the right coronary in 12
ases, and the left circumflex in 4 cases. Neither the
oor-to-balloon time (136  114 min) or the symptom-
nset-to-balloon time (287  138 min), defined as the
nset of persistent symptoms until the first balloon inflation,
orrelated with IMR. Removing the 3 patients who received
brinolytic therapy from the analysis did not significantly
hange the correlation between IMR and peak CK
r WMS.
The mean IMR was 39  26 U with a median value of
2 U. As a point of reference, in a study including patients
ith stable coronary disease and no obvious microvascular
ysfunction, the mean IMR was 22 U (5). There were 3 left
nterior descending infarcts, 7 right coronary artery infarcts,
nd 4 circumflex infarcts with an IMR below the median.
he average distance of the pressure sensor down the vessel
as 9.4  1.7 cm. The mean peak CK was 2,164  1,627
g/ml. The mean WMS at the time of the STEMI was
8  7. At approximately 3-month follow-up (85  32
linical Characteristicsnd Measures of Microvascular Function
Table 1 Clinical Characteristicsand Measures of Microvascular Function
Variable Total (n  28)
Age (yrs) 62.2
Male gender (%) 64
Diabetes (%) 15
Hypertension (%) 50
Hypercholesterolemia (%) 54
Tobacco use (%) 29
IMR 39 26
CFR 2.0 1.1
FFR 0.88 0.12
TIMI flow grade 3 (%) 89
cTFC 23 10
TMPG (%)
0/1 11
2 46
3 43
ST-segment resolution (%) 66
Baseline WMS 28 7
Medication at discharge (%)
Beta-blocker 86
ACE inhibitor 89
Statin 93
CE  angiotensin-converting enzyme; CFR  coronary flow reserve; cTFC  corrected Thrombol-
sis In Myocardial Infarction frame count; FFR  fractional flow reserve; IMR  index of
icrocirculatory refraction; TIMI Thrombolysis In Myocardial Infarction; TMPG Thrombolysis In
yocardial Infarction myocardial perfusion grade; WMS  wall motion score.ays), the meanWMS had improved to 24 7 (p 0.006).
*he left ventricular ejection fraction at the time of the
TEMI was 48  11%. At approximately 3-month follow-
p, the left ventricular ejection fraction had improved to
2  11% (p  0.05).
The IMR correlated significantly with peak CK (R 
.61, p  0.0005), whereas cTFC, TMPG, CFR, and
T-segment resolution did not (Table 2). The IMR also
orrelated with peak CK-MB (R  0.67, p  0.0001);
owever, in 6 patients the peak CK-MB fraction was
eported as 300 ng/ml and not further quantified by our
aboratory. Because of this limitation, we used peak CK as
ur primary biomarker measure of infarct size. In patients in
hom the IMR was greater than the median value of 32 U,
he average peak CK was significantly higher than in those
atients in whom the IMR was less than or equal to the
edian value (3,128  1,634 ng/ml vs. 1,201  911 ng/ml,
 0.002) (Fig. 1). A similar significant difference was
ound when comparing patients above and below the mean
alue of IMR (3,641 1,332 ng/ml vs. 1,209 943 ng/ml,
 0.0001). The only other univariate predictors of peak
K were baseline WMS (R  0.55, p  0.002) and the
bsence of hyperlipidemia (R  0.49, p  0.009). On
ultivariate analysis including these 2 variables and IMR,
MR was the strongest independent predictor of peak CK
p  0.002). The absence of hyperlipidemia was no longer
significant predictor (p  0.33), and baseline WMS was a
eak predictor (p  0.02). The correlation between IMR
nd peak CK was similar if only left anterior descending
nfarcts (R  0.55, p  0.07) or only right coronary artery
nfarcts (R  0.68, p  0.01) were included.
The IMR correlated significantly with the echocardio-
raphic WMS at 3 months (R  0.59, p  0.002), whereas
TFC, TMPG, CFR, and ST-segment resolution did not
Table 2). The IMR also correlated with left ventricular
jection fraction at 3 months (R  0.55, p  0.004). In
atients in whom the IMR was greater than the median
alue of 32 U, the average WMS at 3 months was
ignificantly worse than in those patients in whom the IMR
as less than or equal to the median value (27.9  6.8 vs.
9.5  3.6, p  0.001) (Fig. 2). A similar significant
ifference was found when comparing patients above and
elow the mean value of IMR (29  7 vs. 21  5, p 
.004). The only other significant predictors of 3-month
MS were the baseline WMS (R  0.58, p  0.002) and
orrelation (R Value) Between Measuresf Microvascular Function and Peak CKnd 3-Month WMS
Table 2
Correlation (R Value) Between Measures
of Microvascular Function and Peak CK
and 3-Month WMS
Variable Peak CK 3-Month WMS
IMR 0.61* 0.59†
TMPG 0.05 0.12
CFR 0.32 0.35
ST-segment resolution 0.35 0.34
cTFC 0.02 0.06p  0.0005, †p  0.002, p  NS for all others.
Abbreviations as in Table 1.
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February 5, 2008:560–5 IMR in STEMIhe absence of hyperlipidemia, which, curiously, predicted a
orse WMS (R  0.69, p  0.0001). On multivariate
nalysis including these 2 variables and IMR, IMR was the
trongest independent predictor of 3-month WMS (p 
.003). Baseline WMS was no longer a significant predictor
p  0.11), and the absence of hyperlipidemia was a weak
redictor (p  0.01).
The IMR was the only significant predictor of recovery of
eft ventricular function based on the percent change in
MS (R  0.50, p  0.01). In patients with an IMR 32
, the WMS improved significantly from 25.4  6.6 at
aseline to 19.5  3.6 (p  0.002) at 3 months. In patients
ith an IMR 32 U, the WMS did not change signifi-
antly from baseline to 3 months (29.9 7.0 vs. 27.9 6.8,
 0.44) (Fig. 3).
The IMR correlated weakly with CFR (R  0.38, p 
.06) but did not correlate with TMPG (R  0.26 p 
.18), cTFC (R  0.26, p  0.18), or ST-segment
esolution (R  0.13, p  0.50).
Figure 1 Peak CK With Low Versus High IMR
A comparison of the average peak creatine kinase (CK) in patients presenting
with an index of microcirculatory resistance (IMR) less than or equal to the median
value with those presenting with an IMR greater than the median value.
Figure 2 Three-Month Wall Motion
Score With Low Versus High IMR
A comparison of the wall motion score at 3 months in patients presenting with
an IMR less than or equal to the median value with those presenting with an
IMR greater than the median value. Abbreviations as in Figure 1.piscussion
he main findings of this study are that IMR, an invasive
ire-based, quantitative measure of microvascular function,
orrelates with peak CK in patients undergoing PCI for
cute STEMI. The IMR, measured immediately after
rimary PCI, predicts left ventricular function as assessed by
easuring a WMS from echocardiography at 3-month
ollow-up. The IMR also predicted recovery of left ventric-
lar function at 3-month follow-up. Compared to standard
echniques for assessing microvascular dysfunction, such as
MPG, CFR, and ST-segment resolution, IMR was the
trongest and only significant independent predictor of peak
K and WMS at 3 months.
The importance of the coronary microvasculature has
ecently been highlighted (14). A number of techniques
ave been proposed as methods for evaluating the micro-
irculation in the setting of STEMI. Coronary flow reserve
easured with a Doppler wire has been shown to predict
eft ventricular recovery after STEMI in one study, although
nother study found no correlation (15,16). In addition,
FR is not specific for the microcirculation but interrogates
he epicardial vessel as well; CFR is affected by hemody-
amic perturbations, and measuring CFR with a Doppler
ire can be challenging (6,17,18). Other Doppler-derived
easures of microvascular dysfunction, such as the diastolic
eceleration time and systolic flow reversal, have been
hown to correlate with recovery of left ventricular function
fter PCI for STEMI, but they may be difficult to calculate
mmediately and are dependent on an adequate Doppler
ignal (1).
The TMPG has been extensively evaluated as a determi-
ant of microvascular function and found to be a predictor
f outcomes in the setting of STEMI (2). However, the
nalysis is qualitative, and studies involving similar STEMI
Figure 3 Relation Between Change in WMS and IMR
A comparison of recovery of left ventricular function based on the change in
wall motion score (WMS) from baseline to 3 months in patients presenting with
an IMR less than or equal to the median value with those presenting with an
IMR greater than the median value. Abbreviations as in Figure 1.atient populations have shown wide variations in the
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IMR in STEMI February 5, 2008:560–5ercentage of patients in each grade (19,20). Moreover,
ome investigators have questioned the usefulness of
MPG in studies with smaller sample sizes (19). Like
MPG, ST-segment resolution on the electrocardiogram is
nother simple and readily available method for assessing
issue-level perfusion after PCI for STEMI (21). This
echnique’s limitations include the fact that ST-segment
esolution is generally evaluated in a dichotomous fashion,
hich may mandate large populations to demonstrate sig-
ificant differences between 2 groups.
We have recently validated IMR in an animal model and
ubsequently tested it in stable patients after PCI (3–5).
dditionally, we have found that IMR, unlike CFR, is very
eproducible and not affected by hemodynamic changes (6).
e have also measured IMR in cardiac transplant recipi-
nts, where we have shown that in combination with FFR,
MR provides insight into the changes in microvascular
unction that occur early after transplantation and during
onger term follow-up (7,22). This is the first report
ocumenting the predictive value of measuring IMR in
atients undergoing primary PCI for STEMI.
tudy limitations. Although IMR is relatively easy to
erform and interpret and does not add much time to the
rocedure, it has a number of limitations. Its invasive nature
imits the ability to perform follow-up evaluations in the
ame patients. Moreover, it is inherently dependent upon
he distance down the vessel that the sensor is positioned. In
his study, we placed the sensor in the distal two-thirds of
he culprit vessel. After the procedure, we measured how far
own the vessel the sensor was placed. We found no
orrelation between sensor distance and IMR, suggesting
hat small differences in position likely do not have a major
mpact on IMR.
Another inherent limitation of IMR is that its simplified
orm (distal pressure multiplied by hyperemic mean transit
ime), which was used in this study, may overestimate true
icrovascular resistance if significant collaterals are present.
his occurs because the hyperemic mean transit time, the
ethod used to estimate flow, is a reflection of coronary
ow and not myocardial flow (23). In the presence of
ignificant collaterals, coronary flow underestimates myo-
ardial flow, and resistance is overestimated. A more com-
lex form of IMR that accounts for collateral flow can be
alculated by measuring the coronary wedge pressure as
utlined previously (4,5). Because IMR was measured at the
nd of the procedure, after removal of the epicardial
bstruction, it is unlikely that significant collateral flow was
resent in this study. In addition, in calculating IMR, only
istal coronary pressure was measured instead of calculating
he pressure gradient across the microvasculature by sub-
racting venous pressure from distal coronary pressure. In
atients with large myocardial infarctions in whom the
enous pressure might be elevated, the IMR measured may
ave been falsely higher than it would have been if venous
ressure had been taken into account.A final inherent limitation of IMR is the fact that
yocardial resistance varies depending on the amount of
yocardium interrogated. Theoretically the IMR in the left
nterior descending of a larger heart may be quite different
rom the IMR in the right coronary artery of a smaller heart.
he fact that IMR remained an important predictor of
cute and short-term myocardial damage suggests that this
eature does not have a major impact when assessing IMR
n the setting of STEMI.
This study is limited by its small numbers. However, IMR
emained predictive of myocardial damage despite the size of
he study. The small sample size may explain why the other
easures of microvascular function did not correlate with
yocardial damage in this study. Larger studies will be
ecessary to determine whether IMR can predict clinical
utcomes. Ideally, Doppler-derived parameters of microvascu-
ar injury also would have been assessed and compared to IMR.
linical implications. The ability to risk-stratify patients
ith STEMI at the time of primary PCI by measuring IMR
ay allow earlier application of pharmacologic intervention or
tem-cell therapy to improve myocardial cell salvage in high-
isk patients. By demonstrating the correlation between IMR
nd myocardial damage, this study helps to validate the use of
MR in assessing novel therapies, as was recently done (24) to
valuate adjunctive intracoronary fibrinolytic administration
fter primary PCI in patients with STEMI.
onclusions
he IMR is an independent predictor of acute and short-
erm myocardial damage in patients undergoing primary
CI for STEMI.
eprint requests and correspondence: Dr. William F. Fearon,
tanford University Medical Center, 300 Pasteur Drive, H3554,
tanford, California 94305. E-mail: wfearon@stanford.edu.
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